[go: up one dir, main page]

GR3002113T3 - Quinazoline derivatives - Google Patents

Quinazoline derivatives

Info

Publication number
GR3002113T3
GR3002113T3 GR91400808T GR910400808T GR3002113T3 GR 3002113 T3 GR3002113 T3 GR 3002113T3 GR 91400808 T GR91400808 T GR 91400808T GR 910400808 T GR910400808 T GR 910400808T GR 3002113 T3 GR3002113 T3 GR 3002113T3
Authority
GR
Greece
Prior art keywords
hydrogen
4alkyl
different
same
nar
Prior art date
Application number
GR91400808T
Other languages
English (en)
Inventor
Robert John Ife
Thomas Henry Brown
Colin Andrew Leach
Original Assignee
Smithkline Beecham Intercredit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878728336A external-priority patent/GB8728336D0/en
Priority claimed from GB888820184A external-priority patent/GB8820184D0/en
Application filed by Smithkline Beecham Intercredit filed Critical Smithkline Beecham Intercredit
Publication of GR3002113T3 publication Critical patent/GR3002113T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Chemically Coating (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
GR91400808T 1987-12-03 1991-06-12 Quinazoline derivatives GR3002113T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878728336A GB8728336D0 (en) 1987-12-03 1987-12-03 Compounds
GB888820184A GB8820184D0 (en) 1988-08-25 1988-08-25 Compounds

Publications (1)

Publication Number Publication Date
GR3002113T3 true GR3002113T3 (en) 1992-12-30

Family

ID=26293140

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91400808T GR3002113T3 (en) 1987-12-03 1991-06-12 Quinazoline derivatives

Country Status (16)

Country Link
EP (1) EP0322133B1 (el)
JP (1) JPH02502462A (el)
KR (1) KR900700465A (el)
CN (1) CN1033380A (el)
AT (1) ATE63742T1 (el)
DE (1) DE3862928D1 (el)
ES (1) ES2032024T3 (el)
FI (1) FI893632A7 (el)
GR (1) GR3002113T3 (el)
HU (1) HU203325B (el)
IL (1) IL88507A (el)
NZ (1) NZ227125A (el)
PH (1) PH25508A (el)
PT (1) PT89110B (el)
WO (1) WO1989005297A1 (el)
ZW (1) ZW16588A1 (el)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
US5411963A (en) * 1988-01-29 1995-05-02 Dowelanco Quinazoline derivatives
GT198900008A (es) * 1988-01-29 1990-07-17 Derivados de quinolina, quinazolina y cinolina.
US5114939A (en) * 1988-01-29 1992-05-19 Dowelanco Substituted quinolines and cinnolines as fungicides
IL89027A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Quinazoline derivatives, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
CA2011086A1 (en) * 1989-03-17 1990-09-17 Karl-Heinz Geiss 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
IE63502B1 (en) * 1989-04-21 1995-05-03 Zeneca Ltd Aminopyrimidine derivatives useful for treating cardiovascular disorders
CA2015981A1 (en) * 1989-05-10 1990-11-10 Thomas H. Brown Compounds
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
GB9012592D0 (en) * 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
GB9022644D0 (en) * 1990-10-18 1990-11-28 Ici Plc Heterocyclic compounds
WO1992007844A1 (en) * 1990-11-06 1992-05-14 Pfizer Inc. Quinazolines derivatives for enhancing antitumor activity
JPH06500117A (ja) * 1991-02-20 1994-01-06 フアイザー・インコーポレイテツド 抗腫瘍活性を増強させる２，４−ジアミノキナゾリン誘導体
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 ４−アミノキナゾリン誘導体およびそれを含有する医薬品
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
EP0669324A4 (en) * 1993-09-10 1996-04-03 Eisai Co Ltd CHINAZOLIN DERIVATIVES.
TW334434B (en) * 1995-05-16 1998-06-21 Kanebo Ltd Novel quinazoline compound and anti-tumor agent
WO1997042192A1 (de) * 1996-05-07 1997-11-13 Basf Aktiengesellschaft Imidazo-chinazoline, sie enthaltende mittel und deren verwendung zur bekämpfung von schadpilzen und tierischen schädlingen
IN188411B (el) * 1997-03-27 2002-09-21 Yuhan Corp
GB9708917D0 (en) 1997-05-01 1997-06-25 Pfizer Ltd Compounds useful in therapy
GB9711650D0 (en) * 1997-06-05 1997-07-30 Pfizer Ltd Compounds useful in therapy
AU2960599A (en) * 1998-03-30 1999-10-18 Akira Karasawa Quinazoline derivatives
AU2002361846A1 (en) * 2001-12-21 2003-07-15 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
CA2473796A1 (en) 2002-01-17 2003-07-31 Neurogen Corporation Substituted quinazolin-4-ylamine analogues
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
CN1984660B (zh) * 2003-07-03 2010-12-15 美瑞德生物工程公司 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
US7329664B2 (en) 2003-07-16 2008-02-12 Neurogen Corporation Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
CN101287369A (zh) * 2005-01-03 2008-10-15 美瑞德生物工程公司 治疗脑癌的方法
CA2592900A1 (en) * 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
JP4966958B2 (ja) 2005-03-14 2012-07-04 ノイロサーチ アクティーゼルスカブ カリウムチャネル調節剤及び医療における使用
WO2006105056A2 (en) * 2005-03-28 2006-10-05 Fmc Corporation Insecticidal 2,4-diaminoquinazolines and related derivatives
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
ES2511792T3 (es) 2006-07-25 2014-10-23 Vecta Ltd. Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP
CA2691932A1 (en) * 2007-06-27 2008-12-31 Summit Corporation Plc Use of compounds for preparing anti-tuberculosis agents
MY199989A (en) * 2015-03-04 2023-12-02 Gilead Sciences Inc Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
AU2017318601B2 (en) 2016-09-02 2020-09-03 Gilead Sciences, Inc. Toll like receptor modulator compounds
ES2826748T3 (es) 2016-09-02 2021-05-19 Gilead Sciences Inc Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
CN106518849B (zh) * 2016-10-27 2019-08-16 上海人类基因组研究中心 喹唑啉类化合物及其制备方法和用途
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法
CA3230249A1 (en) * 2021-09-07 2023-03-16 Paul Gregor Compounds and pharmaceutical compositions comprising inhibitors of amyloid peptide interactions with glycosaminoglycans, methods of treatment, and use thereof
JPWO2024101336A1 (el) * 2022-11-07 2024-05-16

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE958197C (de) * 1952-04-18 1957-02-14 Dr Siegfried Skraup Verfahren zur Herstellung von 2, 4-Diaminochinazolin
GB806772A (en) * 1956-03-29 1958-12-31 Wellcome Found Diaminoquinazolines and method of preparing
CH457460A (fr) * 1966-06-20 1968-06-15 Parke Davis & Co Procédé de préparation de quinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
GB1390014A (en) * 1971-05-07 1975-04-09 Koninklijke Pharma Fab Nv Process for the preparation of carbocyclic fused pyrimidine derivatives
US3956495A (en) * 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4098788A (en) * 1977-06-20 1978-07-04 Bristol-Myers Company Process for preparing quinazolines
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones

Also Published As

Publication number Publication date
IL88507A (en) 1993-02-21
PT89110A (pt) 1988-12-01
ATE63742T1 (de) 1991-06-15
FI893632A0 (fi) 1989-07-31
DE3862928D1 (de) 1991-06-27
EP0322133B1 (en) 1991-05-22
CN1033380A (zh) 1989-06-14
ZW16588A1 (en) 1989-06-21
PH25508A (en) 1991-07-24
EP0322133A1 (en) 1989-06-28
WO1989005297A1 (en) 1989-06-15
KR900700465A (ko) 1990-08-13
PT89110B (pt) 1993-03-31
HUT50322A (en) 1990-01-29
NZ227125A (en) 1990-09-26
JPH02502462A (ja) 1990-08-09
ES2032024T3 (es) 1993-01-01
HU203325B (en) 1991-07-29
FI893632A7 (fi) 1989-07-31

Similar Documents

Publication Publication Date Title
GR3002113T3 (en) Quinazoline derivatives
EG18408A (en) Process for preparing novel substituted quinoline derivatives
ES551005A0 (es) Un procedimiento para preparar derivados de tironina
ZA891389B (en) L-amino-3-acylquinoline derivatives their use as inhibitors of gastric secretion
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
DK526087A (da) Antikonvulsive aminosyrederivater
ES557149A0 (es) Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida.
NO861868L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatian-derivater.
EP0334674A3 (en) Use of isoxazolinones as cerebro-active drugs
SE8305362D0 (sv) Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds